{"title":"Immune System Response to Weight Loss among Obese Saudi Non-Alcoholic Fatty Liver Disease Subjects","authors":"Fadwah M Al Sharif","doi":"10.31031/IOD.2020.04.000578","DOIUrl":null,"url":null,"abstract":"Globally, non-alcoholic fatty liver disease (NAFLD) considered as a common chronic liver disorder [1]. Similarly, about 30% of European people have NAFLD [2]. Moreover, about 2550% of worldwide people have NAFLD which is the major cause of abnormal liver enzymes [3]. There is an association between NAFLD and obesity [4]. Abnormal immunological and systemic inflammation parameters are the key for NAFLD pathogenesis [5-8]. However, abnormal immune system performance not only induce NAFLD but also contributes progression and NAFLD associated disorders [9-11]. In addition, obesity is usually associated with abnormal immunological parameters values [12]. Altered immune system competence is usually a common finding associated with obesity subjects and the level of deterioration in immune system performance is related to obesity grade [13]. Similarly, about 30% of some malignant tumors are associated with obesity [14]. Many researchers reported abnormal values of immune system parameters among obese individuals [15-17].","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventions in Obesity & Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31031/IOD.2020.04.000578","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Globally, non-alcoholic fatty liver disease (NAFLD) considered as a common chronic liver disorder [1]. Similarly, about 30% of European people have NAFLD [2]. Moreover, about 2550% of worldwide people have NAFLD which is the major cause of abnormal liver enzymes [3]. There is an association between NAFLD and obesity [4]. Abnormal immunological and systemic inflammation parameters are the key for NAFLD pathogenesis [5-8]. However, abnormal immune system performance not only induce NAFLD but also contributes progression and NAFLD associated disorders [9-11]. In addition, obesity is usually associated with abnormal immunological parameters values [12]. Altered immune system competence is usually a common finding associated with obesity subjects and the level of deterioration in immune system performance is related to obesity grade [13]. Similarly, about 30% of some malignant tumors are associated with obesity [14]. Many researchers reported abnormal values of immune system parameters among obese individuals [15-17].